IL214211A0 - Stable vaccine compositions and methods for preparing the same - Google Patents

Stable vaccine compositions and methods for preparing the same

Info

Publication number
IL214211A0
IL214211A0 IL214211A IL21421111A IL214211A0 IL 214211 A0 IL214211 A0 IL 214211A0 IL 214211 A IL214211 A IL 214211A IL 21421111 A IL21421111 A IL 21421111A IL 214211 A0 IL214211 A0 IL 214211A0
Authority
IL
Israel
Prior art keywords
preparing
methods
same
vaccine compositions
stable vaccine
Prior art date
Application number
IL214211A
Original Assignee
Pharmathene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathene Inc filed Critical Pharmathene Inc
Publication of IL214211A0 publication Critical patent/IL214211A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL214211A 2009-01-22 2011-07-20 Stable vaccine compositions and methods for preparing the same IL214211A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2009/050051 WO2010084298A1 (en) 2009-01-22 2009-01-22 Stable vaccine compositions and methods of use

Publications (1)

Publication Number Publication Date
IL214211A0 true IL214211A0 (en) 2011-08-31

Family

ID=41082348

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214211A IL214211A0 (en) 2009-01-22 2011-07-20 Stable vaccine compositions and methods for preparing the same

Country Status (6)

Country Link
EP (1) EP2381959A1 (en)
JP (1) JP2012515752A (en)
AU (1) AU2009338516A1 (en)
CA (1) CA2750321A1 (en)
IL (1) IL214211A0 (en)
WO (1) WO2010084298A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007303608B2 (en) 2006-09-29 2013-05-02 Takeda Vaccines, Inc. Norovirus vaccine formulations
KR20100083150A (en) 2007-09-18 2010-07-21 리고사이트 파머슈티컬즈 인코퍼레이티드 Method of conferring a protective immune response to norovirus
US9616117B2 (en) 2008-10-02 2017-04-11 Pharmathene, Inc. Anthrax vaccine formulation and uses thereof
EA035442B1 (en) 2011-07-11 2020-06-17 Такеда Вэксинс, Инк. Compositions comprising a buffer, vaccines that comprise compositions comprising a buffer and methods of use thereof
WO2014004578A1 (en) * 2012-06-25 2014-01-03 Emergent Product Development Gaithersburg Inc. Temperature stable vaccine formulations
US10357559B2 (en) 2013-12-27 2019-07-23 Emergent Product Development Gaithersburg Inc. Temperature stable vaccine formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE503491T1 (en) * 2003-02-13 2011-04-15 Becton Dickinson Co IMPROVED ANTHRAX VACCINES AND DELIVERY METHODS
EP2068834A2 (en) * 2006-09-08 2009-06-17 Becton, Dickinson & Company Stable powder formulations of aluma-dsorbed vaccines
EP1972347A1 (en) * 2007-03-19 2008-09-24 Becton, Dickinson and Company, Wagner, Jaconda Stable vaccine powder formulations
GB0801122D0 (en) * 2008-01-22 2008-02-27 Avecia Biolog Ltd Vaccine composition

Also Published As

Publication number Publication date
WO2010084298A1 (en) 2010-07-29
AU2009338516A1 (en) 2011-08-18
CA2750321A1 (en) 2010-07-29
JP2012515752A (en) 2012-07-12
EP2381959A1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
PT2574187T (en) Squalane and isosqualane compositions and methods for preparing the same
ZA201006944B (en) Compositions and methods for preparing and using same
GB201003924D0 (en) Immunogenic composition
HK1167107A1 (en) Vaccine composition comprising 5-cap modified rna 5-cap rna
GB0913681D0 (en) Immunogenic composition
IL223206A0 (en) Vaccine formulations
IL217375A (en) Methods for preparing vesicles and formulations produced therefrom
GB201015132D0 (en) Vaccine composition
IL242592A (en) Immunogenic compositions
PT2402032T (en) Immunogenic composition
EP2285405A4 (en) Vaccine compositions and methods
EP2515940A4 (en) Immunogenic compositions and related methods
GB201005625D0 (en) Immunogenic proteins and compositions
HK1213594A1 (en) Immunogenic compositions and uses thereof
GB201103423D0 (en) Immunogenic proteins and compositions
EP2609931A4 (en) Immunogenic composition
IL214211A0 (en) Stable vaccine compositions and methods for preparing the same
EP2498815A4 (en) Vaccine composition
GB0913680D0 (en) Immunogenic composition
EP2252326A4 (en) Vaccine compositions
IL214127A0 (en) Vaccine compositions
IL220308A0 (en) Vaccine compositions
EP2640418A4 (en) Immunogenic compositions
ZA201301908B (en) Immunogenic compositions
SG2014010433A (en) Stable compositions and methods for preparing the same